The review provides a summary of developments in Australian Government industry assistance, trade policy and foreign investment over the past year. The report finds that continuing to advocate for free and open trade and looking for opportunities to lower tariffs would be the best responses to changes in global trade policy.

This brief examines China's statements on foreign policy issues in the six months to mid-May 2025. It covers trade restrictions between China and the US; Taiwan’s reunification with China; tensions between the US and Europe; and the Russia-Ukraine War.

This briefing note assesses trade and US tariffs, including an explanation and learnings for Australia. It seeks to explain the economic basis for tariffs, the apparent motives and impact of the so-called ‘Liberation Day’ tariffs, the benefits of trade, the exposure of the Australian economy to tariff wars, as well as discussing potential responses.

With the China-Australia Free Trade Agreement now a decade in operation, this analysis provides an Australian assessment of core outcomes against a backdrop of claims by advocates and critics of the deal. It finds a decade on that Australian public support for ChAFTA remains strong.

This report discusses the potential for the Trump administration to ask Australia to water down the Pharmaceutical Benefits Scheme (PBS). This would result in higher medicine prices. The report argues that policies delivering cheaper medicine for Australians should not be considered trade restrictions.